Robert Burke, MD
Cardiovascular Disease · Scottsdale, AZNPI 1679557961
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 37.7% of the total. Reporting peaked in 2019 at $44,895 and has fallen 64.1% since, to $16,125 in 2025. Among cardiovascular disease clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 412 payments — averaging $502.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$78K
- Abbott$65K
- Medtronic$22K
- Boston Scientific$21K
- Edwards Lifesciences$17K
- Inspire Medical Systems, Inc.$3K
- plus $2K from 18 others
Across 6 payments — averaging $8502.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$34K
- Siemens Medical Solutions USA, Inc.$17K
What the payments were for
- Consulting fees$47,05023%
- Speaking & faculty fees$97,32947%
- Travel & lodging$47,96023%
- Food & beverage$14,6327%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 79 | $78,007 |
| Abbott | 123 | $64,617 |
| Medtronic(2 entities) | 54 | $22,413 |
| Boston Scientific | 57 | $20,872 |
| Edwards Lifesciences | 34 | $16,544 |
| Inspire Medical Systems, Inc. | 4 | $2,515 |
| Heartflow, Inc. | 6 | $677 |
| Novartis | 22 | $356 |
| Inari Medical, Inc. | 1 | $171 |
| Philips North America LLC | 3 | $150 |
| ZOLL Respicardia, Inc. | 1 | $145 |
| Amgen | 6 | $104 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $87 |
| Bardy Diagnostics, Inc. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| Pfizer | 3 | $42 |
| Biosense Webster, Inc. | 1 | $25 |
| AstraZeneca | 2 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| B. Braun Interventional Systems Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Terumo Medical Corporation | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mitra Clip system$38,171
- ACUSON SC2000 Diagnostic Ultrasound System$24,891
- ACUSON Origin Diagnostic Ultrasound System$20,832
- MitraClip System$20,130
- COREVALVE EVOLUT R$15,009
- WATCHMAN Access System$13,499
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$7,500
- Edwards SAPIEN 3 Transcatheter Heart Valve$6,902
- CoreValve Evolut$4,443
- LOTUS EDGE$3,375
- Watchman$3,000
- MitraClip$2,606
- Inspire Upper Airway Stimulation System$2,498
- Avalus$2,250
- SC2000$1,460
- EVOQUE$1,051
- Sequoia$860
- FFRct$590
- Tricuspid Valve Repair System$555
- FLOWTRIEVER CATHETER, S$343
How this compares
$206,971 in reported general payments places this provider in the 95th percentile of 423 cardiovascular disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 154 | $207,258 |
| XareltoRivaroxaban | 69 | $77,543 |
| EntrestoSacubitril/Valsartan | 17 | $33,614 |
| Repatha SureclickEvolocumab | 42 | $32,984 |
| Metoprolol Succinate | 334 | $4,631 |
| Rosuvastatin Calcium | 294 | $3,331 |
| Ezetimibe | 61 | $2,336 |
| Atorvastatin Calcium | 282 | $2,230 |
| Flecainide Acetate | 23 | $2,151 |
| Losartan Potassium | 200 | $2,136 |
| Midodrine Hcl | 19 | $1,805 |
| ClopidogrelClopidogrel Bisulfate | 121 | $1,333 |
| Amlodipine Besylate | 162 | $1,214 |
| Lisinopril | 144 | $1,054 |
| Warfarin Sodium | 62 | $1,012 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $42 | $207,258154 claims |
| NovartisEntresto | $356 | $33,61417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 423 cardiovascular disease providers in Arizona.
Other cardiovascular disease in Scottsdale
- Krishnaswami VijayaraghavanScottsdale$927K
- Paul UnderwoodScottsdale$259K
- David RizikScottsdale$128K
- Martin CerdaScottsdale$66K
- Pattara RattanawongScottsdale$43K
- Mayank SardanaScottsdale$36K
- Ashish GuptaPhoenix$1.1M
- Rajkumar SugumaranPhoenix$957K
- Steven MottlTucson$340K
- Omar WaniFlagstaff$244K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.